Retinoblastoma-binding proteins 4 and 9 are important for human pluripotent stem cell maintenance

Experimental Hematology

Volumn 39, Issue 8, 2011, Pages

  O'Connor, Michael D ^a,b   Wederell, Elizabeth ^a   Robertson, Gordon ^c   Delaney, Allen ^c   Morozova, Olena ^c   Poon, Steven S S ^c   Yap, Damian ^c   Fee, John ^c   Zhao, Yongjun ^c   McDonald, Helen ^c   Zeng, Thomas ^c   Hirst, Martin ^c   Marra, Marco A ^c   Aparicio, Samuel A J R ^c   Eaves, Connie J ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA BINDING PROTEIN; RETINOBLASTOMA BINDING PROTEIN 4; RETINOBLASTOMA BINDING PROTEIN 9; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL EXPANSION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; FOXD3 GENE; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NANOG GENE; NERVOUS SYSTEM DEVELOPMENT; ORGANOGENESIS; PLURIPOTENT STEM CELL; POU5F1 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN MOTIF; PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; SOX2 GENE; TRANSCRIPTION REGULATION;

EID: 79960642460     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2011.05.008     Document Type: Article

References (52)

1. Boyer L.A., Mathur D., Jaenisch R. Molecular control of pluripotency. Curr Opin Genet Dev 2006, 16:455-462.
2. Chambers I., Smith A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 2004, 23:7150-7160.
3. Chen L., Daley G.Q. Molecular basis of pluripotency. Hum Mol Genet 2008, 17:R23-R27.
4. Cole M.F., Young R.A. Mapping key features of transcriptional regulatory circuitry in embryonic stem cells. Cold Spring Harb Symp Quant Biol 2008, 73:183-193.
5. Orkin S.H., Wang J., Kim J., et al. The transcriptional network controlling pluripotency in ES cells. Cold Spring Harb Symp Quant Biol 2008, 73:195-202.
6. Pan G., Thomson J.A. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 2007, 17:42-49.
7. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
8. Park I.H., Zhao R., West J.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
9. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
10. Heng J.C., Feng B., Han J., et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 2010, 6:167-174.
11. Nakagawa M., Koyanagi M., Tanabe K., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008, 26:101-106.
12. Andrews P.W., Matin M.M., Bahrami A.R., Damjanov I., Gokhale P., Draper J.S. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem Soc Trans 2005, 33:1526-1530.
13. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
14. Roider H.G., Manke T., O'Keeffe S., Vingron M., Haas S.A. PASTAA: identifying transcription factors associated with sets of co-regulated genes. Bioinformatics 2009, 25:435-442.
15. Adewumi O., Aflatoonian B., et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007, 25:803-816. International Stem Cell Initiative.
16. O'Connor M.D., Kardel M.D., Iosfina I., et al. Alkaline phosphatase-positive colony formation is a sensitive, specific, and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells 2008, 26:1109-1116.
17. Ungrin M., O'Connor M.D., Eaves C.J., Zandstra P.W. Phenotypic analysis of human embryonic stem cells. Curr Protoc Stem Cell Biol 2007, 2:3.1-3.25.
18. Khattra J., Delaney A.D., Zhao Y., et al. Large-scale production of SAGE libraries from microdissected tissues, flow-sorted cells, and cell lines. Genome Res 2007, 17:108-116.
19. Morrissy A.S., Morin R.D., Delaney A., et al. Next-generation tag sequencing for cancer gene expression profiling. Genome Res 2009, 19:1825-1835.
20. Boon K., Osorio E.C., Greenhut S.F., et al. An anatomy of normal and malignant gene expression. Proc Natl Acad Sci U S A 2002, 99:11287-11292.
21. Morozova O., Morozov V., Hoffman B.G., Helgason C.D., Marra M.A. A seriation approach for visualization-driven discovery of co-expression patterns in Serial Analysis of Gene Expression (SAGE) data. PLoS One 2008, 3:e3205.
22. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
23. Reich M., Liefeld T., Gould J., Lerner J., Tamayo P., Mesirov J.P. GenePattern 2.0. Nat Genet 2006, 38:500-501.
24. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57:289-300.
25. Van Belle G., Fisher L.D., Heagerty P.J., Lumley T. Biostatistics: a methodology for the health sciences 2004, John Wiley & Sons, Hoboken, NJ.
26. Hirst M., Delaney A., Rogers S.A., et al. LongSAGE profiling of nine human embryonic stem cell lines. Genome Biol 2007, 8:R113.
27. Boyer L.A., Lee T.I., Cole M.F., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
28. Xu X., Bieda M., Jin V.X., et al. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res 2007, 17:1550-1561.
29. Ivanova N., Dobrin R., Lu R., et al. Dissecting self-renewal in stem cells with RNA interference. Nature 2006, 442:533-538.
30. Dimova D.K., Dyson N.J. The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005, 24:2810-2826.
31. Savatier P., Huang S., Szekely L., Wiman K.G., Samarut J. Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 1994, 9:809-818.
32. Fluckiger A.C., Marcy G., Marchand M., et al. Cell cycle features of primate embryonic stem cells. Stem Cells 2006, 24:547-556.
33. Filipczyk A.A., Laslett A.L., Mummery C., Pera M.F. Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells. Stem Cell Res 2007, 1:45-60.
34. Do J.T., Scholer H.R. Regulatory circuits underlying pluripotency and reprogramming. Trends Pharmacol Sci 2009, 30:296-302.
35. Lim L.S., Loh Y.H., Zhang W., et al. Zic3 is required for maintenance of pluripotency in embryonic stem cells. Mol Biol Cell 2007, 18:1348-1358.
36. He W., Gong K., Zhu G., Smith D.K., Ip N.Y. Membrane distal cytokine binding domain of LIFR interacts with soluble CNTFR in vitro. FEBS Lett 2002, 514:214-218.
37. Blum B., Bar-Nur O., Golan-Lev T., Benvenisty N. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol 2009, 27:281-287.
38. Woitach J.T., Zhang M., Niu C.H., Thorgeirsson S.S. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability. Nat Genet 1998, 19:371-374.
39. Bieda M., Xu X., Singer M.A., Green R., Farnham P.J. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res 2006, 16:595-605.
40. McClellan K.A., Slack R.S. Specific in vivo roles for E2Fs in differentiation and development. Cell Cycle 2007, 6:2917-2927.
41. Dannenberg J.H., van Rossum A., Schuijff L., te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 2000, 14:3051-3064.
42. Ruiz S., Panopoulos A.D., Herrerias A., et al. A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Curr Biol 2011, 21:45-52.
43. Qian Y.W., Wang Y.C., Hollingsworth R.E., Jones D., Ling N., Lee E.Y. A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature 1993, 364:648-652.
44. Chen X., Xu H., Yuan P., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
45. Muller F.J., Laurent L.C., Kostka D., et al. Regulatory networks define phenotypic classes of human stem cell lines. Nature 2008, 455:401-405.
46. Sharov A.A., Ko M.S. Exhaustive search for over-represented DNA sequence motifs with CisFinder. DNA Res 2009, 16:261-273.
47. Kim S.J., Wagner S., Liu F., O'Reilly M.A., Robbins P.D., Green M.R. Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature 1992, 358:331-334.
48. Kuzmichev A., Nishioka K., Erdjument-Bromage H., Tempst P., Reinberg D. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev 2002, 16:2893-2905.
49. Zhang Y., Ng H.H., Erdjument-Bromage H., Tempst P., Bird A., Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1999, 13:1924-1935.
50. Wang J., Rao S., Chu J., et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006, 444:364-368.
51. Liang J., Wan M., Zhang Y., et al. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol 2008, 10:731-739.
52. Bachovchin D.A., Brown S.J., Rosen H., Cravatt B.F. Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes. Nat Biotechnol 2009, 27:387-394.